日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential

CNNM4在胆管癌进展中的作用:对铁死亡和治疗潜力的影响

Mercado-Gómez, Maria; Goikoetxea-Usandizaga, Naroa; Giné, Alvaro Eguileor; Merlos Rodrigo, Miguel A; Afonso, Marta Bento; Azkargorta, Mikel; Zapata-Pavas, Leidy Estefanía; Rejano-Gordillo, Claudia M; Romero, Marta R; Mendizabal, Isabel; Rodrigues, Pedro M; Wu, Hanghang; Rodríguez-Agudo, Rubén; Serrano-Maciá, Marina; Olaizola, Paula; Barrenechea-Barrenechea, Jon Ander; González Recio, Irene; G Fernandez-Barrena, Maite; Overi, Diletta; Gaudio, Eugenio; Schaeper, Ute; Garcia-Longarte, Saioa; Yáñez-Bartolomé, Mariana; Peña-SanFelix, Patricia; Gil-Pitarch, Clàudia; Lapitz, Ainhoa; Michalkova, Hana; Heger, Zbynek; Conter, Carolina; Macias, Rocio I R; Carracedo, Arkaitz; Bañales, Jesús; Moreno, Victor; Lamarca, Angela; Singh, Rajat; Delgado, Teresa Cardoso; Martínez-Cruz, Luis Alfonso; Elortza, Felix; Avila, Matias A; Martín, César; Tian, Tian V; Macarulla, Teresa; Buccella, Daniela; Cubero, Francisco Javier; Calvisi, Diego F; Carpino, Guido; Marin, Jose J G; Rodrigues, Cecília M P; Martinez-Chantar, Maria Luz

Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01

Zanidatamab治疗HER2阳性转移性胆道癌:HERIZON-BTC-01研究的最终结果

Pant, Shubham; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A; Chen, Emerson Y; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Wu, Xiaotian; Zhao, Yi; Garfin, Phillip M; Gable, Jonathon; Harding, James J

Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer

一项针对晚期/转移性复发性胆道癌患者的Ib期多中心研究,评估抗TIM-3(S095018/Sym023)联合抗PD-1(Sym021)的疗效。

Ghiringhelli, Francois; Kim, Richard; Macarulla, Teresa; Moreno, Irene; Abdul Razak, Albiruni; Rodon Ahnert, Jordi; Liao, Chih-Yi; Davis, Sarah Lindsey; Mahipal, Amit; Marron, Thomas; Raimbourg, Judith; Kaplon, Hélène; Geronimi, Julia; Harouki, Najah; Rodrigues, Christelle; Darcel, Pauline; Jakobsen, Janus Schou; Skartved, Niels; Hald, Rikke; Lopez-Ravnborg, Daleen; He, Peng; Ianopoulos, Xenophon; Askoxylakis, Vasileios; Lakhani, Nehal

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response

MAPK通路突变出现在对IDH1抑制剂耐药的胆管癌中,并减弱IFN反应

Wan, Jinkai; Saatcioglu, Hatice Duygu; Ellis, Haley; Aguado-Fraile, Elia; Xu, Qin; Kondo, Hiroshi; Manguso, Robert T; Gritti, Ilaria; Norden, Bryanna L; Noble, Carolina; Corcoran, Ryan B; Lubner, Sam J; Javle, Milind; Abou-Alfa, Ghassan K; Cleary, James M; Kelley, Robin K; Borad, Mitesh J; Macarulla, Teresa; Oh, Do Youn; Daigle, Scott; Gliser, Camelia; Pandya, Susan; Choe, Sung; Tron, Adriana E; Bardeesy, Nabeel

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301

一项针对伴有FGFR2基因融合或重排的晚期胆管癌成人患者的III期临床试验:英菲格替尼对比吉西他滨/顺铂方案的疗效:PROOF 301试验的结果及提前终止的反思

Abou-Alfa, G K; Borbath, I; Roychowdhury, S; Goyal, L; Lamarca, A; Macarulla, T; Shroff, R T; Oh, D-Y; Tamaş, C; Savastano, D M; van Veenhuyzen, D F; Xu, C; Freas, E; Solanas, J; Javle, M M

Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort

Claudin 18.2 在胃食管腺癌中的表达:生物标志物重叠及其与欧洲人群临床结局的关联

Terán, E; Pazo, R; Caritá, L; Alsina, M; Hierro, C; Blanco, C; Reboredo, M; Landolfi, S; Zucchiatti, A; Visa, L; Calvo, A; López, A; Vidal-Tocino, R; Agra, C; Alés, I; Foti, S; García-Paredes, B; Genovesi, V; Fornaro, L; Sauri, T; Macías, I; Martínez, E; Martínez, J; Buges, C; Ribera, P; Herranz, J M; Acosta, D; Vivancos, A; Tabernero, J; Élez, E; Tian, T V; Macarulla, T

NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial

在老年初治转移性胰腺癌患者中,NALIRIFOX 与白蛋白结合型紫杉醇联合吉西他滨的疗效比较:一项关键性 NAPOLI 3 试验的亚组分析

Macarulla, T; Cid, R Pazo; Womack, M S; Gracian, A Cubillo; Zervoudakis, A; Hatoum, H; Chung, V; Patel, A; Paulson, A S; Pant, S; O'Reilly, E M; Hubner, R A; Van Cutsem, E; Bekaii-Saab, T; Zhang, L; Li, J; Chen, H; Maxwell, F; Wainberg, Z A; Melisi, D

Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: A systematic review and meta-analysis

无论解剖位置如何,神经周围侵犯都是胆管癌的预后因素:一项系统评价和荟萃分析

Conti, Sefora; Tissera, Natalia S; Castet, Florian; Basagaña-Farrés, Míriam; Salcedo, María Teresa; Pando, Elizabeth; Dopazo, Cristina; Caritá, Lorenzo; Turpin, Anthony; Garcés, Víctor Navarro; Villacampa, Guillermo; Macarulla, Teresa; Tian, Tian V

Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study

阿特珠单抗联合莫替沙福肽、考比替尼或西卢卡福司α治疗既往接受过治疗的晚期胰腺癌:I/IIb期MORPHEUS-PDAC伞状研究

Manji, Gulam A; Chung, Vincent; Oh, Do-Youn; Lacy, Jill; Lopez, Charles D; Ponz-Sarvisé, Mariano; Macarulla, Teresa; Thomas, Roby; George, Ben; Alistar, Angela; Siveke, Jens T; Xu, Yun; Lau, Janet; Cha, Edward; Kim, Kyu-Pyo; O'Reilly, Eileen M

Clinical advancement in the management of mutant isocitrate dehydrogenase (IDH) cancers

突变型异柠檬酸脱氢酶(IDH)癌症治疗的临床进展

Bridgewater, John; Tabatabai, Ghazaleh; Macarulla, Teresa; Stacchiotti, Silvia